ZimVie earned FDA approval for its new version of the Mobi-C cervical disc, the devicemaker said Aug. 10.
Spinal Tech
Neuralink earned a $280 million series D funding round, the company said in an Aug. 7 tweet.
Curiteva received FDA 510(k) approval for its pedicle and sacroiliac joint navigation instruments, the medtech company said Aug. 8.
Alphatec posted $117 million in second quarter sales.
SynerFuse named Bill Koschak as CFO, the company said Aug. 7.
Anne-Françoise Nesmes, CFO of medical technology company Smith + Nephew, will step down from the role during the second quarter of 2024.
Stryker, Johnson & Johnson and Zimmer Biomet posted their second quarter financial results for 2023, and data on their orthopedic sales.
Globus Medical on Aug. 3 posted second quarter sales of $291.6 million.
NuVasive's CEO Chris Barry remains confident the spine company will meet its planned merger with Globus Medical on schedule, he said in an Aug. 2 earnings call.
ZimVie on Aug. 2 posted $224.9 million in second-quarter sales.
